• Issues related to the disease of diabetes, diabetes therapies and management of the disease of diabetes. Issues related to medical devices and medical device technology. Issues related to medical device sterilization methods. Issues related to the State of Texas and the Texas State Plan Amendment request regarding how the state will administer aspects of Medicaid. Issues related to Pharmacy Benefit Managers (PBMs) - no specific bills, but general discussions on impacts to medical devices in the pharmacy channel and impacts to patients. Issues related to real world evidence and real world data pertaining to medical devices and approval pathways. Issues related to artificial intelligence and predictive algorithms in medical device technology and innovations.

Duration: October 15, 2021 to present

General Issues: Health Issues, Manufacturing, Medicare/Medicaid, Pharmacy, Telecommunications, Insurance

Spending: about $550,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2021: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS)